Income Taxes - Summary of Significant Components of Company's Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
|---|---|---|
| Deferred tax assets: | ||
| Net operating loss carryforwards | $ 51,672 | $ 37,609 |
| Capitalized license and research and development payments | 7,786 | 8,393 |
| Research and development credits | 15,062 | 11,910 |
| Deferred revenue | 11,919 | 17,117 |
| Lease liabilities | 10,105 | 10,519 |
| Accrued bonus | 1,085 | 1,053 |
| Stock compensation | 4,344 | 3,335 |
| Other temporary differences | 289 | 349 |
| Total deferred tax assets | 102,262 | 90,285 |
| Valuation allowance | (93,091) | (80,758) |
| Deferred tax assets | 9,171 | 9,527 |
| Deferred tax liabilities: | ||
| Right-of-use asset | (5,996) | (6,007) |
| Depreciation | $ (3,175) | $ (3,520) |